Nifty
Sensex
:
:
17094.35
57426.92
276.25 (1.64%)
1016.96 (1.80%)

Pharmaceuticals & Drugs

Rating :
34/99

BSE: 526953 | NSE: VENUSREM

205.15
30-Sep-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 204.15
  • 208.20
  • 204.15
  • 203.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  26499
  •  54.74
  •  585.55
  •  177.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 275.96
  • 7.70
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 268.41
  • N/A
  • 0.62

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 41.76%
  • 2.18%
  • 49.97%
  • FII
  • DII
  • Others
  • 0.96%
  • 0.00%
  • 5.13%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.48
  • 9.96
  • 20.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.38
  • 9.49
  • 8.76

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -3.36
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.42
  • 4.77
  • 6.35

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.43
  • 0.49
  • 0.70

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.65
  • 7.61
  • 7.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
143.08
129.81
10.22%
141.94
111.37
27.45%
124.34
121.94
1.97%
202.56
126.07
60.67%
Expenses
128.57
112.99
13.79%
136.39
106.88
27.61%
111.91
103.86
7.75%
175.26
115.42
51.85%
EBITDA
14.51
16.82
-13.73%
5.54
4.50
23.11%
12.44
18.08
-31.19%
27.30
10.65
156.34%
EBIDTM
10.14%
12.96%
3.91%
4.04%
10.00%
14.83%
13.48%
8.45%
Other Income
1.44
1.96
-26.53%
2.25
3.49
-35.53%
1.22
1.83
-33.33%
2.89
12.28
-76.47%
Interest
0.26
0.14
85.71%
0.00
0.96
-100.00%
0.31
1.81
-82.87%
0.03
7.39
-99.59%
Depreciation
7.80
8.62
-9.51%
7.56
9.38
-19.40%
8.64
8.70
-0.69%
8.71
8.61
1.16%
PBT
7.89
10.02
-21.26%
0.23
18.20
-98.74%
4.70
13.86
-66.09%
21.46
14.52
47.80%
Tax
1.00
-1.68
-
0.00
-16.91
-
-0.95
2.21
-
-1.69
1.49
-
PAT
6.89
11.70
-41.11%
0.23
35.11
-99.34%
5.65
11.65
-51.50%
23.15
13.03
77.67%
PATM
4.82%
9.01%
0.16%
31.53%
4.54%
9.56%
11.43%
10.33%
EPS
5.15
8.75
-41.14%
0.17
28.45
-99.40%
4.22
9.44
-55.30%
17.32
10.55
64.17%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
611.92
598.65
548.12
339.33
321.89
372.41
400.04
418.27
463.99
541.56
468.64
Net Sales Growth
25.09%
9.22%
61.53%
5.42%
-13.57%
-6.91%
-4.36%
-9.85%
-14.32%
15.56%
 
Cost Of Goods Sold
392.26
385.45
340.79
174.31
181.95
205.08
227.07
238.51
268.94
300.00
262.26
Gross Profit
219.66
213.20
207.33
165.02
139.94
167.33
172.97
179.77
195.05
241.55
206.38
GP Margin
35.90%
35.61%
37.83%
48.63%
43.47%
44.93%
43.24%
42.98%
42.04%
44.60%
44.04%
Total Expenditure
552.13
536.54
494.35
298.52
289.37
332.94
349.32
337.11
374.81
403.33
348.53
Power & Fuel Cost
-
4.71
4.58
4.73
4.86
4.29
4.14
4.01
3.80
3.38
3.05
% Of Sales
-
0.79%
0.84%
1.39%
1.51%
1.15%
1.03%
0.96%
0.82%
0.62%
0.65%
Employee Cost
-
52.33
46.02
46.02
42.10
39.31
34.27
32.44
32.36
30.45
27.30
% Of Sales
-
8.74%
8.40%
13.56%
13.08%
10.56%
8.57%
7.76%
6.97%
5.62%
5.83%
Manufacturing Exp.
-
31.57
22.86
20.84
21.01
36.10
42.48
15.70
17.29
22.10
20.61
% Of Sales
-
5.27%
4.17%
6.14%
6.53%
9.69%
10.62%
3.75%
3.73%
4.08%
4.40%
General & Admin Exp.
-
16.91
16.45
17.57
11.85
13.52
13.26
11.97
15.67
14.74
11.82
% Of Sales
-
2.82%
3.00%
5.18%
3.68%
3.63%
3.31%
2.86%
3.38%
2.72%
2.52%
Selling & Distn. Exp.
-
45.56
63.64
35.05
27.60
34.65
28.10
34.48
36.75
32.65
23.50
% Of Sales
-
7.61%
11.61%
10.33%
8.57%
9.30%
7.02%
8.24%
7.92%
6.03%
5.01%
Miscellaneous Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
23.50
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
EBITDA
59.79
62.11
53.77
40.81
32.52
39.47
50.72
81.16
89.18
138.23
120.11
EBITDA Margin
9.77%
10.38%
9.81%
12.03%
10.10%
10.60%
12.68%
19.40%
19.22%
25.52%
25.63%
Other Income
7.80
8.31
19.63
5.31
6.09
2.39
4.28
2.01
0.68
0.47
0.44
Interest
0.60
0.48
13.02
13.34
25.41
35.56
36.38
37.98
41.21
29.40
24.63
Depreciation
32.71
33.53
35.28
32.01
33.98
33.83
40.26
41.68
46.00
40.22
33.08
PBT
34.28
36.41
25.11
0.78
-20.77
-27.53
-21.64
3.51
2.65
69.08
62.84
Tax
-1.64
-4.32
-13.21
1.96
-1.15
3.16
-4.56
1.81
-2.51
4.78
5.53
Tax Rate
-4.78%
-11.86%
-27.21%
-24.41%
3.87%
-11.48%
21.07%
51.57%
-94.72%
6.92%
8.80%
PAT
35.92
40.72
61.77
-10.00
-28.57
-30.69
-17.08
1.70
5.16
64.30
57.31
PAT before Minority Interest
35.92
40.72
61.77
-10.00
-28.57
-30.69
-17.08
1.70
5.16
64.30
57.31
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
5.87%
6.80%
11.27%
-2.95%
-8.88%
-8.24%
-4.27%
0.41%
1.11%
11.87%
12.23%
PAT Growth
-49.76%
-34.08%
-
-
-
-
-
-67.05%
-91.98%
12.20%
 
EPS
26.81
30.39
46.10
-7.46
-21.32
-22.90
-12.75
1.27
3.85
47.99
42.77

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
440.45
400.28
323.37
332.52
361.91
388.67
437.62
456.68
461.61
379.13
Share Capital
13.37
12.34
12.34
12.34
12.34
12.34
11.44
11.44
11.44
10.54
Total Reserves
427.08
374.19
311.03
320.18
349.57
376.33
426.18
445.24
450.17
363.81
Non-Current Liabilities
45.95
58.12
95.82
136.68
158.47
179.52
212.05
221.55
161.75
147.18
Secured Loans
0.00
0.09
24.19
61.29
86.60
112.69
134.57
150.95
114.76
103.89
Unsecured Loans
38.68
46.74
47.87
54.73
50.84
49.13
56.47
51.34
25.22
25.22
Long Term Provisions
7.95
7.38
6.63
5.32
4.50
4.29
3.79
3.78
3.31
2.91
Current Liabilities
92.74
97.45
224.58
263.62
230.38
196.81
193.14
162.83
210.99
191.25
Trade Payables
54.29
71.36
36.70
36.00
29.33
29.73
25.14
29.56
31.22
18.76
Other Current Liabilities
33.64
21.10
101.70
110.30
78.47
46.16
42.71
15.96
54.70
58.18
Short Term Borrowings
4.06
4.30
85.58
112.80
121.26
119.16
123.32
115.40
110.08
95.68
Short Term Provisions
0.75
0.68
0.61
4.52
1.32
1.76
1.97
1.91
14.99
18.63
Total Liabilities
579.14
555.85
643.77
732.82
750.76
765.00
842.81
841.06
834.35
717.56
Net Block
240.94
261.68
289.37
364.45
389.20
406.18
452.48
443.65
439.46
401.42
Gross Block
612.50
616.32
623.96
707.02
702.77
686.50
679.57
641.12
587.38
511.00
Accumulated Depreciation
371.57
354.63
334.59
342.57
313.57
280.32
227.09
197.47
147.93
109.58
Non Current Assets
301.10
321.82
349.77
467.39
490.50
505.60
565.75
607.85
562.24
491.97
Capital Work in Progress
25.23
25.11
24.63
64.76
64.76
66.25
80.37
78.30
67.80
47.81
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
34.93
35.03
35.77
38.18
36.53
33.17
32.90
85.91
54.98
42.74
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
278.04
234.03
294.00
265.43
260.27
259.41
277.07
233.21
272.11
225.58
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
125.64
119.99
141.12
142.73
138.17
140.60
143.29
142.87
142.26
128.03
Sundry Debtors
38.60
32.04
30.69
38.04
47.27
47.29
61.59
63.22
64.99
47.11
Cash & Bank
50.40
31.42
2.13
2.81
3.98
3.56
7.07
3.62
4.41
6.36
Other Current Assets
63.40
5.70
55.72
5.15
70.84
67.96
65.12
23.51
60.47
44.08
Short Term Loans & Adv.
58.39
44.88
64.34
76.70
66.00
67.96
65.12
23.51
60.47
44.08
Net Current Assets
185.30
136.59
69.43
1.81
29.88
62.59
83.93
70.38
61.12
34.33
Total Assets
579.14
555.85
643.77
732.82
750.77
765.01
842.82
841.06
834.35
717.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
41.00
131.84
77.60
45.33
31.19
58.93
46.88
67.80
52.65
52.15
PBT
36.41
25.11
0.78
-20.77
-27.53
-21.64
3.51
2.65
69.08
62.84
Adjustment
26.33
21.89
41.56
60.72
66.24
70.61
56.41
83.56
37.21
40.72
Changes in Working Capital
-21.74
61.39
20.82
5.37
-7.52
9.96
-13.04
-18.40
-53.65
-51.41
Cash after chg. in Working capital
41.00
108.39
63.16
45.33
31.19
58.93
46.88
67.80
52.65
52.15
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
23.44
14.44
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-16.63
56.49
-4.75
-11.33
-11.48
-18.32
2.92
-67.18
-94.66
-103.89
Net Fixed Assets
3.42
7.56
124.42
-5.05
-11.74
18.95
-50.18
-67.39
-93.77
-101.63
Net Investments
0.00
0.00
0.00
0.00
28.60
0.00
0.00
0.00
0.00
0.00
Others
-20.05
48.93
-129.17
-6.28
-28.34
-37.27
53.10
0.21
-0.89
-2.26
Cash from Financing Activity
-9.48
-162.24
-73.00
-35.17
-39.23
-44.13
-46.35
-1.42
40.06
55.15
Net Cash Inflow / Outflow
14.90
26.09
-0.15
-1.17
-19.52
-3.51
3.46
-0.79
-1.95
3.41
Opening Cash & Equivalents
28.88
1.94
2.03
3.98
0.00
7.07
3.62
4.41
6.36
2.95
Closing Cash & Equivalent
43.26
28.88
1.94
2.81
-19.52
3.56
7.07
3.62
4.41
6.36

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
329.50
313.18
262.01
269.42
293.23
314.92
382.47
399.13
403.43
355.10
ROA
7.18%
10.30%
-1.45%
-3.85%
-4.05%
-2.12%
0.20%
0.62%
8.29%
8.87%
ROE
9.85%
17.40%
-3.05%
-8.23%
-8.18%
-4.13%
0.38%
1.12%
15.38%
17.04%
ROCE
7.89%
12.37%
0.90%
-0.67%
1.17%
2.00%
5.35%
5.74%
14.06%
14.85%
Fixed Asset Turnover
0.97
0.88
0.51
0.46
0.54
0.59
0.63
0.76
0.99
1.00
Receivable days
21.54
20.89
36.97
48.37
46.34
49.67
54.45
50.42
37.72
33.88
Inventory Days
74.88
86.94
152.66
159.26
136.61
129.51
124.86
112.15
90.94
87.34
Payable days
59.49
57.86
42.82
37.91
30.30
26.74
26.74
27.25
21.28
15.09
Cash Conversion Cycle
36.93
49.96
146.80
169.72
152.65
152.44
152.57
135.32
107.37
106.14
Total Debt/Equity
0.10
0.13
0.68
0.90
0.85
0.80
0.77
0.70
0.63
0.72
Interest Cover
76.69
4.73
0.40
-0.17
0.23
0.41
1.09
1.06
3.35
3.55

News Update:


  • Venus Remedies - Quarterly Results
    30th Jul 2022, 19:05 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.